Open Date
10 Dec 2025
Close Date
12 Dec 2025
Listing Date
17 Dec 2025
Max Investment
₹1,91,360
Price Range
₹438 - ₹460
Lot Size
-
IPO Size
₹871.05Cr
Exchange Symbols


Open Date
Close Date
Listing Date
Max Investment
Price Range
Lot Size
IPO Size
Exchange Symbols
India's and Asia's largest dialysis chain with leadership across our markets.
Scale coupled with asset-light model driving cost efficiencies and operational excellence.
Driving clinical excellence and quality through protocols and advanced technology.
Organic growth augmented by proven track record of acquisitions and integration in India and internationally.
We offer comprehensive dialysis care through our network of clinics from diagnosis to treatment and wellness programs including haemodialysis, home and mobile dialysis, supported by pharmacy. We are India's largest dialysis service provider in terms of number of patients served, clinics, cities covered, treatments performed, revenue, and EBITDA (excluding other income) in Fiscal 2025. (Source: F&S Report) In Fiscal 2025, we served 29,281 patients and completed 2,885,450 treatments in India which represented approximately 10% of the total dialysis patients in India. We have a global network of 519 clinics and are the most widely distributed dialysis network in India with an extensive pan-India network of clinics across 288 cities, as of September 30, 2025 (Source: F&S Report) and 21 States and four Union Territories. In the six months period ended September 30, 2025 and Fiscal 2025, 2024, and 2023, our revenue from operations was Rs. 4,735.01 million, Rs. 7,558.12 million, Rs. 5,661.55 million and Rs. 4,372.95 million, respectively, highest amongst major organized dialysis service chains in India (Source: F&S Report). Our Profit / (loss) for the period / year was Rs. 142.28 million, Rs. 670.96 million, Rs. 351.33 million and Rs. (117.89) million in the six months period ended September 30, 2025, Fiscals 2025, 2024 and 2023, respectively. Our EBITDA (excluding other income) has consistently increased and was Rs. 1,103.10 million, Rs. 1,666.37 million, Rs. 996.58 million and Rs. 485.95 million in the six months period ended September 30, 2025, Fiscals 2025, 2024 and 2023, respectively.
Nephrocare Health Services: IPO Dates
The Nephrocare Health Services IPO opens for subscription on 10 Dec 2025, and closes on 12 Dec 2025. Investors will likely receive their allotment status updates on 15 Dec 2025. Those who get allotted shares can expect them credited to their Demat accounts by 16 Dec 2025. The shares will be officially listed on the stock exchange on 17 Dec 2025.
Nephrocare Health Services: IPO Price Band
The IPO consists of a fresh issue and an offer for sale, with a price band set between ₹438.0 and ₹460.0 per share.Investors can apply within this range. This book-building issue includes a fresh issue worth ₹353.41 crore and an offer for sale valued at ₹ 517.64 crore. The exact listing price will be revealed on 17 Dec 2025, which is when the shares start trading on the exchange.
Nephrocare Health Services: Lot Size and Issue Size
The minimum application lot size is shares, and investors need to apply for at least one lot. The total IPO size is approximately ₹871.05Cr crore.
You will also get notified of your allotment via push notifications and email from Torus Digital.

Get started with us today and
start building your wealth journey
*By clicking, I agree to the T&C and Whatsapp updates.

Congratulations,
Your Digital savings bank account opening journey is complete.